We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$27.5B
AUM Growth
+$4.26B
(+18%)
Cap. Flow
+$26B
Cap. Flow
% of AUM
94.62%
Top 10 Holdings %
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$221M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$206M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$183M |
| 5 |
Apple
AAPL
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$151M |
| 2 |
Johnson & Johnson
JNJ
|
+$149M |
| 3 |
ConocoPhillips
COP
|
+$142M |
| 4 |
Danaher
DHR
|
+$112M |
| 5 |
S&P Global
SPGI
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Consumer Discretionary | 14.55% |
| 3 | Financials | 12.04% |
| 4 | Healthcare | 11.32% |
| 5 | Industrials | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Enact Holdings
ACT
$6.61B
| $944K | ﹤0.01% |
37,580
+6,537
| +21% | +$159K |
|
1327
Nordson
NDSN
$16.5B
| $944K | ﹤0.01% |
3,803
-50,436
| -93% | -$11.2M |
|
1328
CorVel
CRVL
$3.13B
| $944K | ﹤0.01% |
14,628
+11,244
| +332% | +$752K |
|
1329
Life Time Group Holdings
LTH
$9.53B
| $942K | ﹤0.01% |
47,898
-97,742
| -67% | -$1.87M |
|
1330
Douglas Elliman
DOUG
$158M
| $942K | ﹤0.01% |
+424,393
| New | +$1.17M |
|
1331
Monarch Casino & Resort
MCRI
$2.16B
| $941K | ﹤0.01% |
13,351
+6,308
| +90% | +$440K |
|
1332
CRA International
CRAI
$1.11B
| $938K | ﹤0.01% |
9,193
-8,219
| -47% | -$828K |
|
1333
Adams Diversified Equity Fund
ADX
$3.11B
| $936K | ﹤0.01% |
55,703
+36,755
| +194% | +$584K |
|
1334
Banc of California
BANC
$3.26B
| $935K | ﹤0.01% |
80,776
-89,733
| -53% | -$1.04M |
|
1335
Liberty All-Star Equity Fund
USA
$1.77B
| $935K | ﹤0.01% |
144,485
| – | – |
|
1336
Edison International
EIX
$30.6B
| $929K | ﹤0.01% |
+13,379
| New | +$941K |
|
|
OZON
1337
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $924K | ﹤0.01% |
79,666
| – | – |
|
1338
BridgeBio Pharma
BBIO
$16.8B
| $920K | ﹤0.01% |
53,473
-290,312
| -84% | -$4.37M |
|
1339
iShares Core MSCI Pacific ETF
IPAC
$2.63B
| $913K | ﹤0.01% |
+8,550
| New | +$489K |
|
1340
iShares MSCI France ETF
EWQ
$326M
| $912K | ﹤0.01% |
22,922
+19,313
| +535% | +$742K |
|
1341
Iovance Biotherapeutics
IOVA
$2.23B
| $909K | ﹤0.01% |
129,097
+31,066
| +32% | +$222K |
|
1342
Forward Air
FWRD
$487M
| $907K | ﹤0.01% |
+8,545
| New | +$875K |
|
1343
Canadian Imperial Bank of Commerce
CM
$108B
| $905K | ﹤0.01% |
+21,214
| New | +$896K |
|
|
DEN
1344
DELISTED
Denbury Inc.
DEN
| $905K | ﹤0.01% |
+10,494
| New | +$951K |
|
1345
LoveSac
LOVE
$251M
| $904K | ﹤0.01% |
+33,541
| New | +$855K |
|
1346
Construction Partners
ROAD
$5.82B
| $902K | ﹤0.01% |
+28,749
| New | +$823K |
|
1347
Columbus McKinnon
CMCO
$459M
| $900K | ﹤0.01% |
22,136
-354
| -2% | -$13.1K |
|
1348
Iridium Communications
IRDM
$4.83B
| $900K | ﹤0.01% |
+14,485
| New | +$896K |
|
1349
Vanguard Total World Stock ETF
VT
$76.2B
| $900K | ﹤0.01% |
+8,143
| New | +$763K |
|
1350
Westamerica Bancorp
WABC
$1.39B
| $887K | ﹤0.01% |
23,147
-58,683
| -72% | -$2.35M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review
As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.
- Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
- Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
- Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
- Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
- Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
- Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.